Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Fuel Tech FTEK is doing that changes everything Grinds Lower 20260511 GNLB Global Net management highlights stable recurring cash flow trends in its latest quarterly earnings update Kevin Warsh Fed Chair Confirmation Outlook Analysis Is Niagen Bioscience NAGE stock losing bullish momentum Q4 2025 EPS Exceeds Expectations Noah NOAH Stock Attractive Investment Institutional Selling 20260420 How sustainable is Solana HSDT earnings momentum Q3 2025 Better Than Expected The recurring revenue story behind Biglari BH Biglari posts 2337 EPS no analyst estimates yet The hidden strength in Tuniu TOUR most investors miss Touches High 20260508 Heron Therapeutics HRTX Stock Strategic Buy or Not Q4 2025 Profit Surprises MannKind Corporation MNKD Slips 419 Testing 293 Support 20260515 Broadcom Rallies After Wells Fargo Highlights AI Infrastructure Demand Through New Data Center Power Framework Google Unveils First Look at AIPowered Audio Smart Glasses Set for Fall Release FNB Corporation FNB Stock Analysis 064 Gain What to Watch 20260514 Iran Conflict Exposes Vulnerabilities in AI Supply Chain as Chip Sector Scrambles for Key Materials Market Digest Highlights NVIDIA Lear Etsy and Haleon Gentex Corporation GNTX Surges 084 Nearing 2400 Resistance 20260520 Live Oak LOKVW Extends Bull Run with Another 190 Climb 20260521 Copa Holdings Q1 2026 Earnings Strong EPS Beat Highlights Operational Resilience Encompass Health Q1 2026 Earnings EPS Surpasses Estimates by 58 Amid Mixed Market Reaction Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment Kimball Electronics Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Rise GEO Q1 2026 Earnings EPS Surprises to the Upside Despite Flat Revenue Disclosure Brighthouse Financial Holds Steady Near Support as Sector Headwinds Persist First Bank FRBA Slips 08 as NearTerm Resistance Holds Sonoma Pharmaceuticals SNOA Edges Higher Testing Key Resistance at 113 POET Technologies POET Declines 785 as Selling Pressure Builds Key Levels to Watch